Home » SIRS-Lab Acquires Rights of Use to OGT Biochip Technology
SIRS-Lab Acquires Rights of Use to OGT Biochip Technology
The biotech company SIRS-Lab and the Oxford Gene Technology IP have agreed on the licensing of OGT's technology for nucleotide-based biochips. The contract signed in January enables SIRS-Lab to produce biochips using the patented technology and to distribute these products and related services Europe-wide.
Le Figaro (http://bourse.lefigaro.fr/Actualite/Default.asp?Source=PR&NumArticle=99551)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May